Skip to main content

Time in Range News

Time in Range (TIR) is the percentage of time that a person spends with their blood glucose levels in the target range, usually between 70 and 180 mg/dl.

The American Diabetes Association's 81st Scientific Sessions brought together great minds in diabetes for exciting news and discussions. Check out highlights from the...
Full results from the SURPASS trials on the drug tirzepatide shows that this new medication dramatically lowers A1C and weight and is incredibly effective in people with...
The American Diabetes Association’s 81st Scientific Sessions is going strong. Updates from days two and three include promising Omnipod 5 results, Medtronic’s seven-day...
We bring you the most exciting news from day one of the 81st ADA Scientific sessions, including updates on inhaled insulin, digital diabetes management programs,...
Nick Jonas, singer, actor, and advocate for people with diabetes, is launching The Global Movement for Time in Range, an educational ad campaign to raise awareness for...
A remote six-month clinical trial is recruiting 150 children between the ages of two to five whose families are interested in trying automated insulin delivery. The...
We’ve reviewed the latest research to weigh the benefits and drawbacks of intermittent fasting and time-restricted feeding for people with diabetes.
The discovery of insulin promised a new age for an ancient condition but introduced unexpected challenges. James S. Hirsch explores the riveting history of this miracle...
The latest innovations in diabetes technology have brought Time in Range (TIR) to the forefront of diabetes care. Read to learn about the most exciting TIR news from one...
From automated insulin delivery to therapeutic advances to glucose management during COVID-19, read our full coverage of one of the biggest international virtual...
The diaTribe team covers the latest in diabetes technology from the 14th annual ATTD 2021 international conference (set virtually this year). Here are our top highlights...
Time in Range (TIR) is another number for people with diabetes to pay attention to and use to improve their daily diabetes management. We talked with three women in the...
Two diabetes devices from Medtronic – a next-gen continuous glucose monitor that removes fingerstick calibrations and a smart insulin delivery pen that keeps track of...
How to recognize and treat severe hypoglycemia quickly – with emergency glucagon – and avoid a trip to the hospital.
Public speaking professor Alan Uphold shares his experiences with severe low blood sugars and explains why it’s so important to communicate with your loved ones and care...
If you just got a continuous glucose monitoring system, you may be wondering how to use it most effectively and how to understand your glucose data. Read our tips,...
Two studies recently published on the Control-IQ and MiniMed 780G systems show that closed-loop automated insulin delivery significantly improves Time in Range.
A fully virtual six-month clinical trial is recruiting 300 people with type 1 and type 2 diabetes who are interested in trying continuous glucose monitoring (CGM) with...
Emerging evidence shows that variability in your A1C level may put you at a higher risk of stroke and heart disease.
Zegalogue emergency glucagon comes as a pre-filled injection or auto-injector pen and can be used to treat severe hypoglycemia quickly.

Pages